MOGNA; Vera

Patent Applications and Registrations

Patent applications and USPTO patent grants for MOGNA; Vera.The latest application filed is for "homogenisation process for the preparation of a cellular component homogenate".

Company Profile

4.3.6

MOGNA; Vera - Novara IT
MOGNA; Vera - Novara NO
Mogna; Vera - N/A N/A N/A
- NOVARA IT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Homogenisation Process For The Preparation Of A Cellular Component Homogenate App 20220259550 - MOGNA; Vera ; et al.	2022-08-18
Use Of A Cytofluorometry Method For Evaluating The Stability And Viability Of A Biomass Of Freeze-dried Bacterial Cells App 20220195482 - MOGNA; Vera ; et al.	2022-06-23
Method For Preparing A Biomass Of Stable Freeze-dried Bacterial Cells And Determining The Stability Thereof By Means Of A Cytofluorometry Method App 20220195378 - MOGNA; Vera ; et al.	2022-06-23
Mixture Of Probiotic Bacteria Strains For Use In The Treatment Of Allergic Asthma And With Recurrent Wheezing, Preferably In Paediatrict Subjects App 20220175855 - MOGNA; Vera ; et al.	2022-06-09
Compositions comprising live probiotic bacterial cultures of Lactobacillus, Bifidobacterium, Lactococcus, Streptococcus, or Staphylococcus Grant 11,130,938 - Mogna , et al. September 28, 2	2021-09-28
Composition for use in treating or preventing viral or bacterial infections in a subject undergoing anti-tumor chemotherapy, leukemia treatment or aids therapy comprising L. reuteri LER03 and/or L. salivarius LS06 Grant 11,077,153 - Mogna August 3, 2	2021-08-03
Composition for use as a support therapy for treatment of tumours, AIDS and leukaemia Grant 10,933,105 - Mogna March 2, 2	2021-03-02
Composition For Use As A Support Therapy For Treatment Of Tumours, Aids And Leukaemia App 20200197453A1 -	2020-06-25
Bacteria-based Gel Compositions For Topical Applications And Uses Thereof App 20200138880A1 -	2020-05-07
Therapy For Use In The Treatment Of Tumors, Acquired Immunodeficiency Syndrome And Leukemias By Dual Immune Biostimulation App 20190350989 - MOGNA; Giovanni	2019-11-21
Bacterial Composition For Use In Attenuating The Decline In Performance After Exercise App 20180318363 - MOGNA; Giovanni	2018-11-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.